COX

环氧合酶 (COX) 的正式名称是前列腺素内过氧化物合酶 (PTGS),它是一种负责形成重要生物介质前列腺素类物质的酶,包括前列腺素、前列环素和血栓素。通过药物抑制 COX 可以缓解炎症和疼痛症状。抑制环氧合酶活性的药物(如阿司匹林)已经面世约 100 年。已鉴定出两种环氧合酶同工酶,分别称为 COX-1 和 COX-2。在许多情况下,COX-1 酶是组成性产生的(即胃粘膜),而 COX-2 是可诱导的(即炎症部位)。非甾体抗炎药 (NSAID),如阿司匹林和布洛芬,通过抑制 COX 发挥作用。主要的 COX 抑制剂是非甾体抗炎药 (NSAID)。

Cyclooxygenase (COX), officially known as prostaglandin-endoperoxide synthase (PTGS), is an enzyme that is responsible for formation of important biological mediators called prostanoids, including prostaglandins, prostacyclin and thromboxane. Pharmacological inhibition of COX can provide relief from the symptoms of inflammation and pain. Drugs, like Aspirin, that inhibit cyclooxygenase activity have been available to the public for about 100 years. Two cyclooxygenase isoforms have been identified and are referred to as COX-1 and COX-2. Under many circumstances the COX-1 enzyme is produced constitutively (i.e., gastric mucosa) whereas COX-2 is inducible (i.e., sites of inflammation). Non-steroidal anti-inflammatory drugs (NSAID), such as aspirin and ibuprofen, exert their effects through inhibition of COX. The main COX inhibitors are the non-steroidal anti-inflammatory drugs (NSAIDs).

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(rac)-Poriol
5,7,4'-Trihydroxy-6-methylflavanone

(rac)-Poriol (5,7,4'-Trihydroxy-6-methylflavanone) 具有抗氧化活性,可清除自由基 DPPH(IC50 为 0.18 µg/mL),并可在 RAW264.7 中抑制 LPS (MS-X54539) 诱导的 NO 生成(10 μM 时抑制率为 98.35%),具有抗炎活性,且与 iNOS、COX-1、COX-2、TNF-α 和 IL-1β 具有良好的结合亲和力。

70460-58-1
Ligand
(rac)-Poriol
COX-1 ligand 1

COX-1 ligand 1(Compound 44)是一种选择性 COX-1 配体(Kd 或 Ki 值:恒河猴 COX-1 为 22 nM,人 COX-1 为 43 nM),可抑制 [3H]PS13 与人 COX-1 的结合,经 11C 或 18F 放射性标记后可用于 COX-1 成像及精神疾病研究。

Ligand
COX-1 ligand 1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础